Fosamax at center of U.S. controversy surrounding drug's side effects | DENENA | POINTS

Fosamax at center of U.S. controversy surrounding drug’s side effects

Fosamax has already been at the center of several high-profile lawsuits concerning the product’s serious and potentially deadly side effects. The drug is widely prescribed for bone loss, like that suffered by postmenopausal women. Studies link Fosamax to several serious complications including:

  • Osteonecrosis (bone rot) of the jaw and other jaw injuries,
  • Femoral fractures, particularly in women,
  • Esophageal inflammation, and
  • Esophageal cancer.

The FDA has met more than once in special sessions to review Fosamax, Boniva, Actonel, and other bone strengthening drugs. The FDA is reviewing the data concerning the injuries these drugs might cause. These drugs that purportedly strengthen bone are called bisphosphonates. The FDA asserts that the data remains inconclusive regarding their danger and injury potential. Lawsuits assert that drug makers failed to give proper warnings of the risks associated with use of the drugs.

If you have been injured as a result of taking Fosamax or another bisphosphonate drug, contact the experienced Deer Park pharmaceutical injury attorneys at Denena & Points for a free and confidential case evaluation. You could be eligible for financial compensation from the drug maker for your injury.